Ellevest Inc’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-233
| Closed | -$1.94K | – | 500 |
|
|
2023
Q1 | $1.94K | Buy |
+233
| New | +$1.94K | ﹤0.01% | 1448 |
|
|
2022
Q3 | – | Sell |
-96
| Closed | -$1K | – | 1610 |
|
|
2022
Q2 | $1K | Buy |
96
+93
| +3,100% | +$969 | ﹤0.01% | 1210 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1419 |
|
|
2021
Q4 | $0 | Sell |
3
-55
| -95% | – | ﹤0.01% | 1418 |
|
|
2021
Q3 | $1K | Buy |
58
+15
| +35% | +$259 | ﹤0.01% | 1230 |
|
|
2021
Q2 | $1K | Buy |
43
+40
| +1,333% | +$930 | ﹤0.01% | 1121 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1262 |
|
|
2020
Q4 | $0 | Sell |
3
-28
| -90% | – | ﹤0.01% | 1192 |
|
|
2020
Q3 | $0 | Buy |
31
+12
| +63% | – | ﹤0.01% | 1139 |
|
|
2020
Q2 | $0 | Buy |
+19
| New | – | ﹤0.01% | 1135 |
|